Similar Papers

Paper Title
Journal
Date
Author
Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Novel Agents
Chihiro Shimazaki
Clinical Lymphoma Myeloma and Leukemia | VOL. 14
Chihiro ShimazakiChihiro Shimazaki
21 Dec 2013
Bortezomib (BOR) and High Dose Melphalan (HDM) as Conditioning Regimen Before Autologous Stem Cell Transplantation (ASCT) for De Novo Multiple Myeloma (MM): Final Results of the IFM Phase II Study VEL/MEL
Murielle Roussel ... Michel Attal
Blood | VOL. 112
Murielle Roussel, et. al.Murielle Roussel ... Michel Attal
16 Nov 2008
Impact of Duration of Induction Therapy on Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Undergoing Upfront Autologous Stem Cell Transplantation
Rajshekar Chakraborty ... Morie A Gertz
Blood | VOL. 130
Rajshekar Chakraborty, et. al.Rajshekar Chakraborty ... Morie A Gertz
25 Jun 2021
A Phase III Study of Double Autotransplantation Incorporating Bortezomib-Thalidomide-Dexamethasone (VTD) or Thalidomide-Dexamethasone (TD) for Multiple Myeloma: Superior Clinical Outcomes with VTD Compared to TD.
...
Blood | VOL. 114
, et. al. ...
20 Nov 2009
View more papers

More From: Haematologica

Paper Title
Journal
Date
Author
Acute promyelocytic leukemia with TTMV::RARA fusion potentially responds to all-trans retinoic acid/arsenic trioxide treatment.
Qingyu Xu ... Hong-Hu Zhu
Haematologica | VOL. -
Qingyu Xu, et. al.Qingyu Xu ... Hong-Hu Zhu
23 Jan 2025
Myeloma cell growth suppression by osteoblast-derived extracellular vesicles: the creation of a non-permissive niche for myeloma cells by bone-forming osteoblasts.
Sooha Kim ... Masahiro Abe
Haematologica | VOL. -
Sooha Kim, et. al.Sooha Kim ... Masahiro Abe
23 Jan 2025
Opportunistic bone density assessment using pre-treatment [18F]FDG-PET/CT identifies fracture risk in lymphoma patients undergoing corticosteroid-containing chemotherapy.
Genevieve Douglas ... Eliza A Hawkes
Haematologica | VOL. -
Genevieve Douglas, et. al.Genevieve Douglas ... Eliza A Hawkes
23 Jan 2025
Heat exposure and pediatric immune thrombocytopenia in Japan from 2011 to 2022: a nationwide space-time-stratified case-crossover study.
Nobutoshi Nawa ... Takeo Fujiwara
Haematologica | VOL. -
Nobutoshi Nawa, et. al.Nobutoshi Nawa ... Takeo Fujiwara
23 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.